University Of Maryland, Baltimore
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Drug: 20-herb formulationDrug: Placebo
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 104
- Registration Number
- NCT03300804
- Locations
- 🇭🇰
Medical Gastroenterelogy Clinic Of the Prince Of Wales, Chinese University of Hong Kong, Shatin, Hong Kong
Incredible Years Program for Parents of Children with Autism
Not Applicable
Terminated
- Conditions
- Autism Spectrum Disorder
- Interventions
- Behavioral: Incredible Years - ASDOther: Circle of Parents
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 27
- Registration Number
- NCT03300128
- Locations
- 🇺🇸
Onslow County Partnership for Children, Jacksonville, North Carolina, United States
Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
Phase 3
Active, not recruiting
- Conditions
- Typhoid
- Interventions
- Biological: Vi-Typhoid Conjugate Vaccine (Vi-TCV)Biological: Meningococcal A Conjugate Vaccine (MCV-A)
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 30000
- Registration Number
- NCT03299426
- Locations
- 🇲🇼
Malawi Liverpool Wellcome Trust Clinical Research Programme, Queen Elizabeth Central Hospital College of Medicine, Blantyre, Malawi
Craniofacial Applications of 3D Printing
Withdrawn
- Conditions
- Facial Fracture
- Interventions
- Procedure: 3D template
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03292679
- Locations
- 🇺🇸
Arthur J Nam, Baltimore, Maryland, United States
SBIRT Intervention for Gambling Behaviors
Not Applicable
Completed
- Conditions
- Gambling Disorder
- Interventions
- Behavioral: SBIRT for GambingOther: Enhanced Control
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 81
- Registration Number
- NCT03287583
- Locations
- 🇺🇸
University of Kentucky, SMART clinic, Lexington, Kentucky, United States
The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine
Phase 1
Withdrawn
- Conditions
- Cognitive Change
- Interventions
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03281694
Circuitry-Guided Smoking Cessation in Schizophrenia
Not Applicable
Completed
- Conditions
- Smoking CessationNicotine AddictionSchizophrenia
- Interventions
- Device: Sham TMS stimulationDevice: Active TMS stimulation
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 44
- Registration Number
- NCT03281629
- Locations
- 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD
Phase 4
Withdrawn
- Conditions
- Congestive Heart FailureHypertension
- Interventions
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03279861
Pharmacokinetics of Metronidazole Dermal Products
Early Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 7
- Registration Number
- NCT03271983
- Locations
- 🇺🇸
General Clinical Research Center (GCRC) at the University of Maryland Medical Center, Baltimore, Maryland, United States
Brain Biomarker on Inflammation Response
Phase 1
Withdrawn
- Conditions
- Schizophrenia
- Interventions
- Biological: LPSOther: Placebo
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03271814
© Copyright 2025. All Rights Reserved by MedPath